Serotonin Receptors as a Potential Target in the Treatment of Alzheimer’s Disease
Alzheimer’s disease (AD) is the most common cause of dementia worldwide that has an increasing impact on aging societies. Besides its critical role in the control of various physiological functions and behavior, brain serotonin (5-HT) system is involved in the regulation of migration, proliferation,...
Gespeichert in:
| Veröffentlicht in: | Biochemistry (Moscow) 2023-12, Vol.88 (12-13), p.2023-2042 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2042 |
|---|---|
| container_issue | 12-13 |
| container_start_page | 2023 |
| container_title | Biochemistry (Moscow) |
| container_volume | 88 |
| creator | Eremin, Dmitrii V. Kondaurova, Elena M. Rodnyy, Aleksander Ya Molobekova, Camilla A. Kudlay, Dmitrii A. Naumenko, Vladimir S. |
| description | Alzheimer’s disease (AD) is the most common cause of dementia worldwide that has an increasing impact on aging societies. Besides its critical role in the control of various physiological functions and behavior, brain serotonin (5-HT) system is involved in the regulation of migration, proliferation, differentiation, maturation, and programmed death of neurons. At the same time, a growing body of evidence indicates the involvement of 5-HT neurotransmission in the formation of insoluble aggregates of β-amyloid and tau protein, the main histopathological signs of AD. The review describes the role of various 5-HT receptors and intracellular signaling cascades induced by them in the pathological processes leading to the development of AD, first of all, in protein aggregation. Changes in the functioning of certain types of 5-HT receptors or associated intracellular signaling mediators prevent accumulation of β-amyloid plaques and tau protein neurofibrillary tangles. Based on the experimental data, it can be suggested that the use of 5-HT receptors as new drug targets will not only improve cognitive performance in AD, but will be also important in treating the causes of AD-related dementia. |
| doi_str_mv | 10.1134/S0006297923120064 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2955268653</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A777647175</galeid><sourcerecordid>A777647175</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-2b1a3d5c9fa59c1cebf9fbc0976b95a5b5471651f097b897e20c24a78f590f93</originalsourceid><addsrcrecordid>eNp1kc1OGzEUha2qqKS0D9ANstQNmwH_jO3xMqJAKyGBSPYjj3MdjGbGwXYWdMVr8Ho8CY5Ci1pAtmT7nu9cHesi9I2SQ0p5fTQjhEimlWacsnKtP6AJlaSpOKnJRzTZyNVG30WfU7opT0Y0_4R2eVNLVtdqgmYziCGH0Y_4CiyscogJm7LxZcgwZm96PDdxCRkXJF8DnkcweSgSDg5P-9_X4AeIj_cPCf_wCUyCL2jHmT7B1-dzD81PT-bHP6vzi7Nfx9PzynJNc8U6avhCWO2M0JZa6Jx2nSVayU4LIzpRKyoFdaXSNVoBI5bVRjVOaOI030MH27arGG7XkHI7-GSh780IYZ1apoVgspGCF_T7f-hNWMexhCsUkZJLKekLtTQ9tH50IUdjN03bqVJKljhKFOrwDaqsBQzehhGcL_V_DHRrsDGkFMG1q-gHE-9aStrNHNtXcyye_efA626AxV_Hn8EVgG2BVKRxCfHlR-93fQIzn6US</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2906636661</pqid></control><display><type>article</type><title>Serotonin Receptors as a Potential Target in the Treatment of Alzheimer’s Disease</title><source>SpringerLink Journals - AutoHoldings</source><creator>Eremin, Dmitrii V. ; Kondaurova, Elena M. ; Rodnyy, Aleksander Ya ; Molobekova, Camilla A. ; Kudlay, Dmitrii A. ; Naumenko, Vladimir S.</creator><creatorcontrib>Eremin, Dmitrii V. ; Kondaurova, Elena M. ; Rodnyy, Aleksander Ya ; Molobekova, Camilla A. ; Kudlay, Dmitrii A. ; Naumenko, Vladimir S.</creatorcontrib><description>Alzheimer’s disease (AD) is the most common cause of dementia worldwide that has an increasing impact on aging societies. Besides its critical role in the control of various physiological functions and behavior, brain serotonin (5-HT) system is involved in the regulation of migration, proliferation, differentiation, maturation, and programmed death of neurons. At the same time, a growing body of evidence indicates the involvement of 5-HT neurotransmission in the formation of insoluble aggregates of β-amyloid and tau protein, the main histopathological signs of AD. The review describes the role of various 5-HT receptors and intracellular signaling cascades induced by them in the pathological processes leading to the development of AD, first of all, in protein aggregation. Changes in the functioning of certain types of 5-HT receptors or associated intracellular signaling mediators prevent accumulation of β-amyloid plaques and tau protein neurofibrillary tangles. Based on the experimental data, it can be suggested that the use of 5-HT receptors as new drug targets will not only improve cognitive performance in AD, but will be also important in treating the causes of AD-related dementia.</description><identifier>ISSN: 0006-2979</identifier><identifier>EISSN: 1608-3040</identifier><identifier>DOI: 10.1134/S0006297923120064</identifier><identifier>PMID: 38462447</identifier><language>eng</language><publisher>Moscow: Pleiades Publishing</publisher><subject>Alzheimer's disease ; Biochemistry ; Biomedical and Life Sciences ; Biomedicine ; Bioorganic Chemistry ; Care and treatment ; Cognitive ability ; Dementia ; Dementia disorders ; Development and progression ; Intracellular ; Intracellular signalling ; Life Sciences ; Microbiology ; Neurodegenerative diseases ; Neurofibrillary tangles ; Neurotransmission ; Protein interaction ; Proteins ; Receptors ; Review ; Senile plaques ; Serotonin ; Serotonin receptors ; Tau protein ; Therapeutic targets ; β-Amyloid</subject><ispartof>Biochemistry (Moscow), 2023-12, Vol.88 (12-13), p.2023-2042</ispartof><rights>Pleiades Publishing, Ltd. 2023</rights><rights>COPYRIGHT 2023 Springer</rights><rights>Pleiades Publishing, Ltd. 2023.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c391t-2b1a3d5c9fa59c1cebf9fbc0976b95a5b5471651f097b897e20c24a78f590f93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1134/S0006297923120064$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1134/S0006297923120064$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38462447$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Eremin, Dmitrii V.</creatorcontrib><creatorcontrib>Kondaurova, Elena M.</creatorcontrib><creatorcontrib>Rodnyy, Aleksander Ya</creatorcontrib><creatorcontrib>Molobekova, Camilla A.</creatorcontrib><creatorcontrib>Kudlay, Dmitrii A.</creatorcontrib><creatorcontrib>Naumenko, Vladimir S.</creatorcontrib><title>Serotonin Receptors as a Potential Target in the Treatment of Alzheimer’s Disease</title><title>Biochemistry (Moscow)</title><addtitle>Biochemistry Moscow</addtitle><addtitle>Biochemistry (Mosc)</addtitle><description>Alzheimer’s disease (AD) is the most common cause of dementia worldwide that has an increasing impact on aging societies. Besides its critical role in the control of various physiological functions and behavior, brain serotonin (5-HT) system is involved in the regulation of migration, proliferation, differentiation, maturation, and programmed death of neurons. At the same time, a growing body of evidence indicates the involvement of 5-HT neurotransmission in the formation of insoluble aggregates of β-amyloid and tau protein, the main histopathological signs of AD. The review describes the role of various 5-HT receptors and intracellular signaling cascades induced by them in the pathological processes leading to the development of AD, first of all, in protein aggregation. Changes in the functioning of certain types of 5-HT receptors or associated intracellular signaling mediators prevent accumulation of β-amyloid plaques and tau protein neurofibrillary tangles. Based on the experimental data, it can be suggested that the use of 5-HT receptors as new drug targets will not only improve cognitive performance in AD, but will be also important in treating the causes of AD-related dementia.</description><subject>Alzheimer's disease</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Bioorganic Chemistry</subject><subject>Care and treatment</subject><subject>Cognitive ability</subject><subject>Dementia</subject><subject>Dementia disorders</subject><subject>Development and progression</subject><subject>Intracellular</subject><subject>Intracellular signalling</subject><subject>Life Sciences</subject><subject>Microbiology</subject><subject>Neurodegenerative diseases</subject><subject>Neurofibrillary tangles</subject><subject>Neurotransmission</subject><subject>Protein interaction</subject><subject>Proteins</subject><subject>Receptors</subject><subject>Review</subject><subject>Senile plaques</subject><subject>Serotonin</subject><subject>Serotonin receptors</subject><subject>Tau protein</subject><subject>Therapeutic targets</subject><subject>β-Amyloid</subject><issn>0006-2979</issn><issn>1608-3040</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kc1OGzEUha2qqKS0D9ANstQNmwH_jO3xMqJAKyGBSPYjj3MdjGbGwXYWdMVr8Ho8CY5Ci1pAtmT7nu9cHesi9I2SQ0p5fTQjhEimlWacsnKtP6AJlaSpOKnJRzTZyNVG30WfU7opT0Y0_4R2eVNLVtdqgmYziCGH0Y_4CiyscogJm7LxZcgwZm96PDdxCRkXJF8DnkcweSgSDg5P-9_X4AeIj_cPCf_wCUyCL2jHmT7B1-dzD81PT-bHP6vzi7Nfx9PzynJNc8U6avhCWO2M0JZa6Jx2nSVayU4LIzpRKyoFdaXSNVoBI5bVRjVOaOI030MH27arGG7XkHI7-GSh780IYZ1apoVgspGCF_T7f-hNWMexhCsUkZJLKekLtTQ9tH50IUdjN03bqVJKljhKFOrwDaqsBQzehhGcL_V_DHRrsDGkFMG1q-gHE-9aStrNHNtXcyye_efA626AxV_Hn8EVgG2BVKRxCfHlR-93fQIzn6US</recordid><startdate>20231201</startdate><enddate>20231201</enddate><creator>Eremin, Dmitrii V.</creator><creator>Kondaurova, Elena M.</creator><creator>Rodnyy, Aleksander Ya</creator><creator>Molobekova, Camilla A.</creator><creator>Kudlay, Dmitrii A.</creator><creator>Naumenko, Vladimir S.</creator><general>Pleiades Publishing</general><general>Springer</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20231201</creationdate><title>Serotonin Receptors as a Potential Target in the Treatment of Alzheimer’s Disease</title><author>Eremin, Dmitrii V. ; Kondaurova, Elena M. ; Rodnyy, Aleksander Ya ; Molobekova, Camilla A. ; Kudlay, Dmitrii A. ; Naumenko, Vladimir S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-2b1a3d5c9fa59c1cebf9fbc0976b95a5b5471651f097b897e20c24a78f590f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Alzheimer's disease</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Bioorganic Chemistry</topic><topic>Care and treatment</topic><topic>Cognitive ability</topic><topic>Dementia</topic><topic>Dementia disorders</topic><topic>Development and progression</topic><topic>Intracellular</topic><topic>Intracellular signalling</topic><topic>Life Sciences</topic><topic>Microbiology</topic><topic>Neurodegenerative diseases</topic><topic>Neurofibrillary tangles</topic><topic>Neurotransmission</topic><topic>Protein interaction</topic><topic>Proteins</topic><topic>Receptors</topic><topic>Review</topic><topic>Senile plaques</topic><topic>Serotonin</topic><topic>Serotonin receptors</topic><topic>Tau protein</topic><topic>Therapeutic targets</topic><topic>β-Amyloid</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eremin, Dmitrii V.</creatorcontrib><creatorcontrib>Kondaurova, Elena M.</creatorcontrib><creatorcontrib>Rodnyy, Aleksander Ya</creatorcontrib><creatorcontrib>Molobekova, Camilla A.</creatorcontrib><creatorcontrib>Kudlay, Dmitrii A.</creatorcontrib><creatorcontrib>Naumenko, Vladimir S.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemistry (Moscow)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eremin, Dmitrii V.</au><au>Kondaurova, Elena M.</au><au>Rodnyy, Aleksander Ya</au><au>Molobekova, Camilla A.</au><au>Kudlay, Dmitrii A.</au><au>Naumenko, Vladimir S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serotonin Receptors as a Potential Target in the Treatment of Alzheimer’s Disease</atitle><jtitle>Biochemistry (Moscow)</jtitle><stitle>Biochemistry Moscow</stitle><addtitle>Biochemistry (Mosc)</addtitle><date>2023-12-01</date><risdate>2023</risdate><volume>88</volume><issue>12-13</issue><spage>2023</spage><epage>2042</epage><pages>2023-2042</pages><issn>0006-2979</issn><eissn>1608-3040</eissn><abstract>Alzheimer’s disease (AD) is the most common cause of dementia worldwide that has an increasing impact on aging societies. Besides its critical role in the control of various physiological functions and behavior, brain serotonin (5-HT) system is involved in the regulation of migration, proliferation, differentiation, maturation, and programmed death of neurons. At the same time, a growing body of evidence indicates the involvement of 5-HT neurotransmission in the formation of insoluble aggregates of β-amyloid and tau protein, the main histopathological signs of AD. The review describes the role of various 5-HT receptors and intracellular signaling cascades induced by them in the pathological processes leading to the development of AD, first of all, in protein aggregation. Changes in the functioning of certain types of 5-HT receptors or associated intracellular signaling mediators prevent accumulation of β-amyloid plaques and tau protein neurofibrillary tangles. Based on the experimental data, it can be suggested that the use of 5-HT receptors as new drug targets will not only improve cognitive performance in AD, but will be also important in treating the causes of AD-related dementia.</abstract><cop>Moscow</cop><pub>Pleiades Publishing</pub><pmid>38462447</pmid><doi>10.1134/S0006297923120064</doi><tpages>20</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0006-2979 |
| ispartof | Biochemistry (Moscow), 2023-12, Vol.88 (12-13), p.2023-2042 |
| issn | 0006-2979 1608-3040 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2955268653 |
| source | SpringerLink Journals - AutoHoldings |
| subjects | Alzheimer's disease Biochemistry Biomedical and Life Sciences Biomedicine Bioorganic Chemistry Care and treatment Cognitive ability Dementia Dementia disorders Development and progression Intracellular Intracellular signalling Life Sciences Microbiology Neurodegenerative diseases Neurofibrillary tangles Neurotransmission Protein interaction Proteins Receptors Review Senile plaques Serotonin Serotonin receptors Tau protein Therapeutic targets β-Amyloid |
| title | Serotonin Receptors as a Potential Target in the Treatment of Alzheimer’s Disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T10%3A55%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serotonin%20Receptors%20as%20a%20Potential%20Target%20in%20the%20Treatment%20of%20Alzheimer%E2%80%99s%20Disease&rft.jtitle=Biochemistry%20(Moscow)&rft.au=Eremin,%20Dmitrii%20V.&rft.date=2023-12-01&rft.volume=88&rft.issue=12-13&rft.spage=2023&rft.epage=2042&rft.pages=2023-2042&rft.issn=0006-2979&rft.eissn=1608-3040&rft_id=info:doi/10.1134/S0006297923120064&rft_dat=%3Cgale_proqu%3EA777647175%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2906636661&rft_id=info:pmid/38462447&rft_galeid=A777647175&rfr_iscdi=true |